Building a vaccine at light speed: mRNA COVID vaccine development

Bringing messenger RNA (mRNA) technology to the COVID-19 vaccine race means taking advantage of the platform’s flexible, scalable attributes, said a pharmaceutical executive, speaking at RAPS Euro Convergence. However, executing the race from pre-clinical molecule construction to advanced clinical trials required coordination and execution at unprecedented pace and scale.